Newsroom
Sorted by: Latest
-
Maurel & Prom : Activité 9 mois 2026
PARIS--(BUSINESS WIRE)--Regulatory News: Maurel & Prom (Paris:MAU): Production du Groupe en part M&P de 39 126 bep/j sur les neuf premiers mois de 2026, en hausse de 4% par rapport à 2025, avec une accélération au T3 (+8% par rapport au T2) Production en part M&P de 13 710 b/j au Gabon Production en part M&P de 3 973 b/j en Angola Production de gaz en part M&P de 67,0 Mpc/j en Tanzanie Production de gaz en part M&P de 10,3 Mpc/j en Colombie Production d’huile en part M&a...
-
Maurel & Prom: Activity for the First Nine Months of 2026
PARIS--(BUSINESS WIRE)--Regulatory News: Maurel & Prom (Paris:MAU): M&P working interest production for the first nine months of 2026: 39,126 boepd, up 4% compared with 2025, with an acceleration in Q3 (+8% versus Q2) M&P working interest production of 13,710 bopd in Gabon M&P working interest production of 3,973 bopd in Angola M&P working interest gas production of 67.0 mmcfd in Tanzania M&P working interest gas production of 10.3 mmcfd in Colombia M&P Iberoamerica...
-
NFL Biosciences Receives Regulatory Approval to Begin Its Phase 2 TONIC Trial for Smoking and Nicotine Cessation
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing immunotherapies for smoking and nicotine cessation, announced today that it has obtained the necessary approvals from the French National Agency for Medicines and Health Products Safety (ANSM) and the Committee for the Protection of Human Subjects (CPP) to begin its Phase 2 TONIC study evaluating NFL-102 for smoking and nicotine cessation....
-
NFL Biosciences obtient les autorisations réglementaires pour démarrer son étude de phase 2 TONIC dans le sevrage tabagique et nicotinique
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL Biosciences (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des immunothérapies pour le sevrage tabagique et nicotinique, annonce aujourd’hui avoir obtenu les autorisations nécessaires auprès de l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) et du Comité de protection des personnes (CPP), pour démarrer son étude de phase 2 TONIC évaluant NFL-102 dans le sevrage tabagiqu...
-
Financial Services Compensation Scheme (FSCS) Selects Capgemini as Technology Partner
PARIS--(BUSINESS WIRE)--Capgemini has been selected by the UK’s Financial Services Compensation Scheme (FSCS) to support its technology and operational priorities....
-
Pershing Square Holdings, Ltd. UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 20 October 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today released its regular weekly Net Asset Value (“NAV”) and performance returns on its website, https://pershingsquareholdings.com/performance/net-asset-value-and-returns/. The NAV and returns were computed as of the close of business on Tuesday, 20 October 2026. PSH NAV per share as of close of busine...
-
TRADING UPDATE - October 2026
AMSTERDAM--(BUSINESS WIRE)--Regulatory News: 7.00am BST 22 October 2026 RELX, the global provider of information-based analytics and decision tools, reports strong underlying revenue growth for the first nine months of 2026 and reaffirms the full year outlook. Highlights Underlying revenue growth year to date +7% Our improving long-term growth trajectory continues to be driven by the ongoing shift in business mix towards higher growth analytics and decision tools that deliver enhanced value to...
-
RELX PLC UK Regulatory Announcement: TRADING UPDATE - October 2026
LONDON--(BUSINESS WIRE)-- 7.00am BST 22 October 2026 TRADING UPDATE - October 2026 RELX, the global provider of information-based analytics and decision tools, reports strong underlying revenue growth for the first nine months of 2026 and reaffirms the full year outlook. Highlights Underlying revenue growth year to date +7% Our improving long-term growth trajectory continues to be driven by the ongoing shift in business mix towards higher growth analytics and decision tools that deliver enhanc...
-
IQM Quantum Computers Announces Conference Call to Report Third Quarter 2026 Financial Results on November 5, 2026
ESPOO, Finland--(BUSINESS WIRE)--IQM Quantum Computers will host a conference call and live webcast on Thursday, November 5, 2026 to discuss its third-quarter 2026 financial results....
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- The Trafford Centre Finance Limited GBP 188,500,000 Class A3 Floating Rate Secured Notes Due 2038 ISSUE NAME. Our Ref. B20276 ISIN Code. XS0222488396 TOTAL INTEREST AMT. CURRENCY CODE. GBP DAY BASIS. Actual/Actual LEAP (A009) NUM OF DAYS. 92 INTEREST RATE. 4.59282 PCT VALUE DATE. 28/10/2026 INTEREST PERIOD. 28/07/2026 TO 28/10/2026 GBP 2,182,155.74 POOL FACTOR. N/A...